SCA
CVS icon

Salient Capital Advisors’s CVS Health CVS Stock Holding History

Salient Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,567
Closed -$202K – 222
2017
Q1 		$202K Sell
2,567
-284
-10% -$22.7K ﹤0.01% 248
2016
Q4 		$225K Sell
2,851
-842
-23% -$68.1K ﹤0.01% 232
2016
Q3 		$329K Buy
3,693
+1
+0% +$94 0.01% 196
2016
Q2 		$353K Sell
3,692
-7,863
-68% -$784K 0.01% 194
2016
Q1 		$1.2M Sell
11,555
-1,422
-11% -$138K 0.03% 112
2015
Q4 		$1.27M Sell
12,977
-10,722
-45% -$1.05M 0.03% 108
2015
Q3 		$2.29M Sell
23,699
-1,801
-7% -$189K 0.06% 93
2015
Q2 		$2.67M Buy
25,500
+2,103
+9% +$215K 0.05% 100
2015
Q1 		$2.42M Sell
23,397
-7,953
-25% -$805K 0.05% 98
2014
Q4 		$3.02M Sell
31,350
-490
-2% -$43.2K 0.06% 94
2014
Q3 		$2.53M Buy
31,840
+5,994
+23% +$473K 0.05% 106
2014
Q2 		$1.95M Buy
25,846
+4,596
+22% +$347K 0.04% 105
2014
Q1 		$1.59M Buy
21,250
+15,524
+271% +$1.1M 0.04% 109
2013
Q4 		$410K Buy
+5,726
New +$368K 0.01% 162

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Salient Capital Advisors's CVS Position: Q2 2017 in Review

Salient Capital Advisors sold out of CVS Health (CVS) in Q2 2017, closing a stake of 2,567 shares — an estimated $202K sold.

Salient Capital Advisors first reported a position in CVS in Q4 2013 and held it in 14 quarters. The position peaked at $3.02M in Q4 2014. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

  • Salient Capital Advisors reported no remaining CVS Health position as of Q2 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 2,567 CVS Health shares in Q2 2017, an estimated $202K.
  • Salient Capital Advisors first reported a position in CVS Health in Q4 2013 and held it in 14 quarters.
  • Salient Capital Advisors's CVS Health position peaked at $3.02M in Q4 2014.
  • 1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on Salient Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.